Vijay K. T. Alagappan
Tufts Medical Center(US)Progenics Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Neonatal Respiratory Health Research, Pulmonary Hypertension Research and Treatments, Inhalation and Respiratory Drug Delivery
Most-Cited Works
- → Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study(2013)161 cited
- → Enhanced Bronchial Expression of Extracellular Matrix Proteins in Chronic Obstructive Pulmonary Disease(2006)137 cited
- → Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption(2005)129 cited
- → Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND): A Randomized Clinical Trial(2016)125 cited
- → Role of Extracellular Matrix and Its Regulators in Human Airway Smooth Muscle Biology(2006)106 cited
- → Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study(2013)73 cited
- → Proinflammatory Cytokines Upregulate mRNA Expression and Secretion of Vascular Endothelial Growth Factor in Cultured Human Airway Smooth Muscle Cells(2005)49 cited
- → Molecular mechanisms in chronic obstructive pulmonary disease(2007)41 cited
- → Angiogenesis and Vascular Remodeling in Chronic Airway Diseases(2013)36 cited
- Transforming growth factor-beta 1 induces angiogenesis in vitro via VEGF production in human airway smooth muscle cells.(2011)